We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Study of LM-302 in Patients With Advance Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT05161390
Recruitment Status : Recruiting
First Posted : December 17, 2021
Last Update Posted : December 30, 2021
Information provided by (Responsible Party):
LaNova Medicines Limited ( LaNova Medicines Zhejiang Co., Ltd. )

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : March 10, 2025
Estimated Study Completion Date : June 8, 2025